Remove astrazeneca-proposes-adding-lynparza-imfinzi-endometrial-cancer-race-heats
article thumbnail

ESMO: AstraZeneca proposes adding Lynparza to Imfinzi as endometrial cancer race heats up

Fierce Pharma

After two immunotherapies demonstrated their power against endometrial cancer, AstraZeneca now suggests that adding Merck-partnered Lynparza to its Imfinzi may offer another option.

230
230